Vitamin b3 and Psoriasis - a phase IV clinical study of FDA data

Summary:

Psoriasis is reported as a side effect among people who take Vitamin b3 (niacin), especially for people who are female, 60+ old, also take Vitamin B12, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Psoriasis when taking Vitamin b3. It is created by eHealthMe based on reports of 1,797 people who have side effects when taking Vitamin b3 from the FDA, and is updated regularly.

What is Vitamin b3?

Vitamin b3 has active ingredients of niacin. It is often used in energy increased. eHealthMe is studying from 1,907 Vitamin b3 users. Check the latest studies of Vitamin b3.

What is Psoriasis?

Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 1,476 drugs and 1,694 conditions by eHealthMe. Check the latest studies of Psoriasis.

On Jul, 26, 2026

1,797 people reported to have side effects when taking Vitamin b3.
Among them, 31 people (1.73%) have Psoriasis.

Among these 31 people:

What is the gender of people who have Psoriasis when taking Vitamin b3? *

female: 74.19 %
male: 25.81 %

What is the age of people who have Psoriasis when taking Vitamin b3? *

What are other drugs people take besides Vitamin b3? *

What are other side effects people have besides Psoriasis? *

Drug Ineffective: 11 people, 35.48%
Stress And Anxiety: 11 people, 35.48%
Pain In Extremity: 9 people, 29.03%
Headache (pain in head): 9 people, 29.03%
Itching: 9 people, 29.03%
Hair Loss: 8 people, 25.81%
Joint Pain: 8 people, 25.81%
Rashes (redness): 7 people, 22.58%
Coronary Artery Occlusion (complete obstruction of blood flow in a coronary artery): 7 people, 22.58%
Colitis (inflammation of colon): 7 people, 22.58%

What are the existing conditions these people have? *

High Blood Pressure: 12 people, 38.71%
High Blood Cholesterol: 12 people, 38.71%
Pain: 9 people, 29.03%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 9 people, 29.03%
Diabetes: 8 people, 25.81%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 22.58%
Insomnia (sleeplessness): 6 people, 19.35%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 16.13%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 16.13%
Cardiac Disorder: 4 people, 12.90%

* Approximation only. Some reports may have incomplete information.

Do you take Vitamin b3 and have Psoriasis?

- Check whether Psoriasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vitamin b3:

Vitamin b3 (1,907 reports)

Psoriasis treatments and more:

Psoriasis (508,163 reports)

Browse all side effects of Vitamin b3:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Psoriasis:

Psoriasis (1,476 drugs)

Browse all the conditions that are associated with Psoriasis:

Psoriasis (1,694 conditions)

Related publications that referenced our studies

Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
Loebl T, Raskin S, "A novel case report: acute manic psychotic episode after treatment with niacin", The Journal of neuropsychiatry and clinical neurosciences, 2013 Jan .
Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
Loebl T, Raskin S, "A novel case report: acute manic psychotic episode after treatment with niacin", The Journal of neuropsychiatry and clinical neurosciences, 2013 Jan .
Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on niacin (the active ingredients of Vitamin b3) and Vitamin b3 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.